Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS (Q57498761)

Philip van Damme

9

0 references

Martin R. Turner

Martin R. Turner

31

0 references

Pamela Shaw

Pamela Shaw

28

0 references

Mamede de Carvalho

7

Mamede de Carvalho

0 references

Sanna-Kaisa Herukka

13

Sanna-Kaisa Herukka

0 references

Albert C. Ludolph

34

Albert C. Ludolph

0 references

Wim Robberecht

26

Wim Robberecht

0 references

Peter M Andersen

5

Peter M. Andersen

0 references

Julian Grosskreutz

11

Julian Grosskreutz

0 references

Susanne Petri

22

Magdalena Kuźma-Kozakiewicz

Susanne Petri

0 references

17

Magdalena Kuzma-Kozakiewicz

0 references

Robert Bowser

6

Robert Bowser

0 references

Janine Kirby

16

Janine Kirby

0 references

Koen Poesen

23

Koen Poesen

0 references

author name string

Claude Jardel

2

0 references

François Salachas

3

0 references

Foudil Lamari

4

0 references

Júlia Costa

8

0 references

Elizabeth Gray

10

0 references

María Hernández-Barral

12

0 references

André Huss

14

0 references

Andreas Jeromin

15

0 references

Maria del Mar Amador

18

0 references

Jesús S. Mora

19

0 references

Claudia Morelli

20

0 references

Petra Muckova

21

0 references

Heidrun Rhode

24

0 references

Anna-Karin Rikardsson

25

0 references

Ana I. Rodríguez Mahillo

27

0 references

Vincenzo Silani

29

0 references

Petra Steinacker

30

0 references

Erdem Tüzün

32

0 references

Berrak Yetimler

33

0 references

Markus Otto

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

35

0 references

publication date

11 April 2016

0 references

published in

0 references

volume

17

0 references

issue

5-6

0 references

page(s)

404-413

0 references

cites work

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Axonal damage markers in cerebrospinal fluid are increased in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

A specific ELISA for measuring neurofilament heavy chain phosphoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

pNfH is a promising biomarker for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Elevated neurofilament levels in neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

CSF biomarker variability in the Alzheimer's Association quality control program

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913

Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2016.1167913